Back to Search Start Over

Oncogenic pathways impinging on the G2-restriction point

Authors :
Floris Foijer
H te Riele
Lodewyk F. A. Wessels
M Simonis
M. van Vliet
Peter K. Sorger
Ron M. Kerkhoven
Stem Cell Aging Leukemia and Lymphoma (SALL)
Damage and Repair in Cancer Development and Cancer Treatment (DARE)
Restoring Organ Function by Means of Regenerative Medicine (REGENERATE)
Source :
ONCOGENE, 27(8), 1142-1154. Nature Publishing Group
Publication Year :
2008

Abstract

In the absence of mitogenic stimuli, cells normally arrest in G(1/0), because they fail to pass the G1-restriction point. However, abrogation of the G1-restriction point (by loss of the retinoblastoma gene family) reveals a second-restriction point that arrests cells in G2. Serum-starvation-induced G2 arrest is effectuated through inhibitory interactions of p27(KIP1) and p21(CIP1) with cyclins A and B1 and can be reversed through mitogen re-addition. In this study, we have investigated the pathways that allow cell cycle re-entry from this G2 arrest. We provide evidence that recovery from G2 arrest depends on the rat sarcoma viral oncogene (RAS) and phosphatidylinositol-3 kinase pathways and show that oncogenic hits, such as overexpression of c-MYC or mutational activation of RAS can abrogate the G2-restriction point. Together, our results provide new mechanistic insight into multistep carcinogenesis.

Details

Language :
English
ISSN :
09509232
Volume :
27
Issue :
8
Database :
OpenAIRE
Journal :
ONCOGENE
Accession number :
edsair.doi.dedup.....700413075615673e6f853c52504f26ec
Full Text :
https://doi.org/10.1038/sj.onc.1210724